Back to Results
First PageMeta Content
Pharmaceuticals policy / Morpholines / Rivaroxaban / Thiophenes / Health / Deep vein thrombosis / Direct Xa inhibitor / Ministry of Health / Enoxaparin sodium / Anticoagulants / Medicine / Pharmacology


Rivaroxaban for PE Drug Decision Summary
Add to Reading List

Document Date: 2014-10-14 17:07:05

Open Document

File Size: 328,20 KB

Share Result on Facebook

Company

Manufacturer Bayer Canada Inc. / Drug Review / Drug Coverage Decision Limited / /

IndustryTerm

patient groups / /

MedicalCondition

pulmonary embolism / /

Organization

Pharmaceutical Services Division / Drug Benefit Council / Information None Ministry of Health Medical Beneficiary & Pharmaceutical Services Division Page / PharmaCare / Ministry of Health / Canadian Drug Expert Committee / /

Position

physician / Governor / /

Product

vitamin K / /

ProvinceOrState

Prince Edward Island / British Columbia / /

PublishedMedium

the Common Drug Review / /

URL

www.health.gov.bc.ca/pharmacare / http /

SocialTag